CNBX Pharmaceuticals, Inc. (CNBX)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 29, 16:00
CNBX Pharmaceuticals Total Liabilities (Quarterly) : 2.548M for Feb. 28, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.31M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 260.70M |
| Fulcrum Therapeutics, Inc. | 13.47M |
| Definium Therapeutics, Inc. | 122.44M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0149M |
| Shareholders Equity (Quarterly) | -2.534M |
| Debt to Equity Ratio | -0.46 |
| Current Ratio | 0.0058 |
| Net Debt Paydown Yield | 28.92% |